Related references
Note: Only part of the references are listed.The Role of Intracellular 3′5′-Cyclic Adenosine Monophosphate (cAMP) in Atherosclerosis
Panayotis Fantidis
CURRENT VASCULAR PHARMACOLOGY (2010)
Design and Rationale of the PROTECT Study: A Placebo-controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function
Beth Davison Weatherley et al.
JOURNAL OF CARDIAC FAILURE (2010)
Rolofylline, an Adenosine A(sub 1)-Receptor Antagonist, in Acute Heart Failure.
Barry M. Massie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: The Northern Manhattan Study (NOMAS)
Takeki Suzuki et al.
AMERICAN HEART JOURNAL (2008)
The PROTECT Pilot Study: A Randomized, Placebo-Controlled, Dose-Finding Study of the Adenosine A1 Receptor Antagonist Rolofylline in Patients With Acute Heart Failure and Renal Impairment
Gad Cotter et al.
JOURNAL OF CARDIAC FAILURE (2008)
The adenosine kinase hypothesis of epileptogenesis
Deflev Boison
PROGRESS IN NEUROBIOLOGY (2008)
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure - The VERITAS Randomized controlled trials
John J. V. McMurray et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
The effects of KW-3902, an adenosine A1-receptor antagonist, on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance
Michael M. Givertz et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment
Howard C. Dittrich et al.
JOURNAL OF CARDIAC FAILURE (2007)
Effects of multiple oral doses of an A1 adenosine antagonist, BG9928, in patients with heart failure -: Results of a placebo-controlled, dose-escalation study
Barry Greenberg et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE
JGF Cleland et al.
EUROPEAN JOURNAL OF HEART FAILURE (2006)
Adenosine and epilepsy: From therapeutic rationale to new therapeutic strategies
D Boison
NEUROSCIENTIST (2005)
Actions of adenosine at its receptors in the CNS: Insights from knockouts and drugs
BB Fredholm et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2005)
What can Adenosine Neuromodulation do for Neuroprotection?
J. A. Ribeiro
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2005)
Heart failure etiology and response to milrinone in decompensated heart failure - Results from the OPTIME-CHF study
GM Felker et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Intracerebral adenosine infusion improves neurological outcome after transient focal ischemia in rats
H Kitagawa et al.
NEUROLOGICAL RESEARCH (2002)
A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke
JP Mohr et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
